RetroVirox Inc.
RetroVirox is a privately-held biotechnology company founded in 2008 and dedicated to discovering new treatments for patients with infectious diseases. RetroVirox is developing novel drugs to eradicate HIV infection and also to treat infections with highly pathogenic viruses (arenavirus) utilizing company's proprietary technologies.